UBS Group
CNS icon

UBS Group’s Cohen & Steers CNS Stock Holding History

UBS Group’s Portfolio CNS Stock Details CNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.24M Buy
147,711
+67,029
+83% +$4.37M ﹤0.01% 3444
2025
Q4 		$5.07M Sell
80,682
-62,876
-44% -$4.09M ﹤0.01% 4016
2025
Q3 		$9.42M Buy
143,558
+85,236
+146% +$6.25M ﹤0.01% 3364
2025
Q2 		$4.39M Sell
58,322
-35,001
-38% -$2.69M ﹤0.01% 4015
2025
Q1 		$7.49M Sell
93,323
-143,231
-61% -$12.2M ﹤0.01% 3361
2024
Q4 		$21.8M Buy
236,554
+167,674
+243% +$16.6M ﹤0.01% 2228
2024
Q3 		$6.61M Buy
68,880
+54,838
+391% +$4.66M ﹤0.01% 2779
2024
Q2 		$1.02M Sell
14,042
-33,512
-70% -$2.38M ﹤0.01% 4410
2024
Q1 		$3.66M Sell
47,554
-7,599
-14% -$542K ﹤0.01% 3305
2023
Q4 		$4.18M Sell
55,153
-54,012
-49% -$3.25M ﹤0.01% 2977
2023
Q3 		$6.84M Sell
109,165
-2,826
-3% -$179K ﹤0.01% 2281
2023
Q2 		$6.49M Buy
111,991
+93,176
+495% +$5.44M ﹤0.01% 2335
2023
Q1 		$1.2M Buy
18,815
+4,651
+33% +$324K ﹤0.01% 3944
2022
Q4 		$914K Buy
14,164
+2,932
+26% +$184K ﹤0.01% 4154
2022
Q3 		$704K Sell
11,232
-185
-2% -$13.2K ﹤0.01% 4044
2022
Q2 		$726K Sell
11,417
-2,679
-19% -$203K ﹤0.01% 3990
2022
Q1 		$1.21M Sell
14,096
-4,541
-24% -$376K ﹤0.01% 3908
2021
Q4 		$1.72M Buy
18,637
+8,300
+80% +$769K ﹤0.01% 3869
2021
Q3 		$866K Buy
10,337
+61
+0.6% +$5.17K ﹤0.01% 4308
2021
Q2 		$843K Sell
10,276
-9,868
-49% -$712K ﹤0.01% 4321
2021
Q1 		$1.32M Buy
20,144
+4,794
+31% +$328K ﹤0.01% 3973
2020
Q4 		$1.14M Buy
15,350
+5,159
+51% +$340K ﹤0.01% 3902
2020
Q3 		$568K Sell
10,191
-8,290
-45% -$512K ﹤0.01% 4081
2020
Q2 		$1.26M Sell
18,481
-8,024
-30% -$484K ﹤0.01% 3304
2020
Q1 		$1.2M Sell
26,505
-9,266
-26% -$586K ﹤0.01% 3200
2019
Q4 		$2.25M Buy
35,771
+21,766
+155% +$1.38M ﹤0.01% 3435
2019
Q3 		$769K Buy
14,005
+4,566
+48% +$242K ﹤0.01% 4192
2019
Q2 		$486K Buy
9,439
+2,963
+46% +$145K ﹤0.01% 4320
2019
Q1 		$274K Sell
6,476
-7,076
-52% -$275K ﹤0.01% 4410
2018
Q4 		$465K Buy
13,552
+3,327
+33% +$123K ﹤0.01% 4329
2018
Q3 		$415K Buy
10,225
+4,130
+68% +$173K ﹤0.01% 4542
2018
Q2 		$254K Buy
6,095
+2,712
+80% +$109K ﹤0.01% 4782
2018
Q1 		$138K Sell
3,383
-2,058
-38% -$86.4K ﹤0.01% 5019
2017
Q4 		$258K Buy
5,441
+755
+16% +$33.3K ﹤0.01% 4745
2017
Q3 		$185K Buy
4,686
+2,277
+95% +$90.4K ﹤0.01% 4893
2017
Q2 		$98K Sell
2,409
-652
-21% -$26K ﹤0.01% 5178
2017
Q1 		$123K Sell
3,061
-2,860
-48% -$103K ﹤0.01% 4955
2016
Q4 		$199K Sell
5,921
-1,471
-20% -$53.8K ﹤0.01% 4792
2016
Q3 		$316K Buy
7,392
+1,695
+30% +$71.7K ﹤0.01% 4224
2016
Q2 		$230K Buy
5,697
+3,327
+140% +$131K ﹤0.01% 4461
2016
Q1 		$93K Sell
2,370
-39,530
-94% -$1.24M ﹤0.01% 5040
2015
Q4 		$1.28M Sell
41,900
-2,428
-5% -$73K ﹤0.01% 3205
2015
Q3 		$1.22M Buy
44,328
+34,509
+351% +$1.06M ﹤0.01% 3174
2015
Q2 		$334K Sell
9,819
-1,747
-15% -$65.9K ﹤0.01% 4429
2015
Q1 		$474K Sell
11,566
-838
-7% -$35.7K ﹤0.01% 4184
2014
Q4 		$522K Buy
+12,404
New +$519K ﹤0.01% 4160

Other funds holding CNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

UBS Group's CNS Position: Q1 2026 in Review

UBS Group increased its Cohen & Steers (CNS) stake by 83% in Q1 2026, buying an estimated $4.37M and bringing the position to 147,711 shares worth $9.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3444.

UBS Group first reported a position in CNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $21.8M in Q4 2024. 294 funds tracked by Wall St. Rank hold CNS as of Q1 2026.

  • UBS Group held 147,711 shares of Cohen & Steers worth $9.24M as of Q1 2026.
  • UBS Group bought 67,029 Cohen & Steers shares in Q1 2026, an estimated $4.37M.
  • Cohen & Steers made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3444 holding.
  • UBS Group first reported a position in Cohen & Steers in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Cohen & Steers position peaked at $21.8M in Q4 2024.
  • 294 funds tracked by Wall St. Rank held Cohen & Steers as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.